Symbol Name ID |
Lep
leptin MGI:104663 |
* | Aspects of the system are reported to show a normal phenotype. |
! | Indicates phenotype varies with strain background. |
Darker colors indicate more annotations |
Human Phenotypes | Decreased T cell activation |
Hypertriglyceridemia |
Insulin-resistant diabetes mellitus |
Type II diabetes mellitus |
Hyperinsulinemia |
Insulin resistance |
Decreased serum leptin |
Decreased serum testosterone concentration |
Decreased serum estradiol |
Disease(s) Associated with LEP | |||||||||
congenital leptin deficiency | |||||||||
type 2 diabetes mellitus |
Mouse Phenotypes | homeostasis/metabolism phenotype |
abnormal response to cardiac infarction |
abnormal vascular wound healing |
abnormal insulin secretion |
decreased insulin secretion |
increased insulin secretion |
increased susceptibility to diet-induced obesity |
impaired adaptive thermogenesis |
increased blood urea nitrogen level |
abnormal circulating glucose level |
increased fasting circulating glucose level |
decreased circulating glucose level |
hypoglycemia |
increased circulating glucose level |
hyperglycemia |
abnormal circulating hormone level |
decreased circulating testosterone level |
increased circulating corticosterone level |
decreased circulating follicle stimulating hormone level |
decreased circulating luteinizing hormone level |
decreased circulating prolactin level |
decreased circulating insulin level |
increased circulating insulin level |
decreased circulating leptin level |
increased circulating leptin level |
abnormal circulating pancreatic peptide level |
decreased circulating growth hormone level |
abnormal circulating cholesterol level |
increased circulating HDL cholesterol level |
increased circulating LDL cholesterol level |
increased circulating VLDL cholesterol level |
increased circulating cholesterol level |
decreased circulating free fatty acids level |
increased circulating free fatty acids level |
decreased circulating triglyceride level |
increased circulating triglyceride level |
decreased circulating tumor necrosis factor level |
decreased body temperature |
abnormal urine catecholamine level |
abnormal oxygen consumption |
decreased oxygen consumption |
increased oxygen consumption |
abnormal glucose homeostasis |
impaired glucose tolerance |
decreased liver glycogen level |
increased urine glucose level |
increased insulin sensitivity |
insulin resistance |
abnormal hormone level |
abnormal corticosterone level |
increased adrenocorticotropin level |
decreased pituitary hormone level |
increased pituitary hormone level |
increased liver cholesterol level |
increased cholesterol level |
abnormal lipid level |
decreased liver triglyceride level |
increased liver triglyceride level |
abnormal protein level |
abnormal urine homeostasis |
albuminuria |
abnormal nucleotide metabolism |
|
Availability | Mouse Genotype | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lepm1Yst/Lepm1Yst | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lepob/Lepob | * | ! | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leptm1.2Gvcao/Leptm1.2Gvcao | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tg(Apcs-Lep)1Yog/0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leptm1.1Gvcao/Leptm1.1Gvcao Tg(Adipoq-cre)1Evdr/0 (conditional) |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|